Barriers to inclusion of older adults in randomised controlled clinical trials on Non-Hodgkin's lymphoma: a systematic review.

@article{Bellera2013BarriersTI,
  title={Barriers to inclusion of older adults in randomised controlled clinical trials on Non-Hodgkin's lymphoma: a systematic review.},
  author={Carine A. Bellera and Delphine Praud and Aur{\'e}lie Petit-Mon{\'e}ger and Pippa McKelvie-Sebileau and Pierre Soubeyran and Simone Mathoulin-P{\'e}lissier},
  journal={Cancer treatment reviews},
  year={2013},
  volume={39 7},
  pages={812-7}
}
BACKGROUND The majority of Non-Hodgkin's lymphoma (NHL) patients are over 65 years. Management is challenging, especially for aggressive lymphoma, and appropriate assessment of efficacy and tolerance specific to this population is crucial. OBJECTIVES To assess the representation of older patients in randomised controlled trials (RCT) in NHL, examining whether trial eligibility criteria prevent participation, and whether appropriate primary endpoints such as toxicity, quality of life, or… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 1 time. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 11 extracted citations

Consideration of comorbidity in treatment decision making in multidisciplinary cancer team meetings: a systematic review.

Annals of oncology : official journal of the European Society for Medical Oncology • 2015
View 1 Excerpt

Improving the Evidence Base for Treating Older Adults With Cancer: American Society of Clinical Oncology Statement.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology • 2015
View 1 Excerpt

Personalizing therapy for older adults with lymphoid malignancies: options and obstacles.

American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting • 2014

Similar Papers

Loading similar papers…